We are live on
!
Find out more
Ensign Peak Advisors Portfolio holdings
AUM
$53.7B
1-Year Est. Return
29.47%
This Fund
S&P 500
This Quarter
Est. Return
+8.67%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
–
AUM
$49.6B
AUM Growth
+$3.06B
(+6.6%)
Cap. Flow
-$463M
Cap. Flow
% of AUM
-0.93%
Top 10 Holdings %
Top 10 Hldgs %
23.4%
Holding
1,890
New
65
Increased
583
Reduced
472
Closed
69
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$108M |
| 2 |
Ford
F
|
+$83.1M |
| 3 |
State Street Blackstone Senior Loan ETF
SRLN
|
+$79.6M |
| 4 |
General Motors
GM
|
+$74.6M |
| 5 |
Newmont
NEM
|
+$62.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$89.4M |
| 2 |
Hartford Financial Services
HIG
|
+$61.5M |
| 3 |
Enterprise Products Partners
EPD
|
+$59.5M |
| 4 |
Tesla
TSLA
|
+$56.7M |
| 5 |
Lam Research
LRCX
|
+$55.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.18% |
| 2 | Financials | 15.21% |
| 3 | Healthcare | 14.87% |
| 4 | Consumer Discretionary | 11.27% |
| 5 | Communication Services | 9.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
476
United Therapeutics
UTHR
$26.3B
| $8.49M | 0.02% |
47,325
-2,165
| -4% | -$412K |
|
477
Arrowhead Research
ARWR
$12B
| $8.37M | 0.02% |
101,096
-5,370
| -5% | -$400K |
|
|
XM
478
DELISTED
Qualtrics International Inc. Class A Common Stock
XM
| $8.37M | 0.02% |
218,680
-78,725
| -26% | -$2.76M |
|
479
Everest Group
EG
$15.4B
| $8.31M | 0.02% |
32,960
+26,090
| +380% | +$6.79M |
|
|
CTLT
480
DELISTED
CATALENT, INC.
CTLT
| $8.3M | 0.02% |
76,817
+4,748
| +7% | +$509K |
|
481
Penumbra
PEN
$12.6B
| $8.3M | 0.02% |
30,300
| – | – |
|
482
Strategy Inc
MSTR
$36B
| $8.21M | 0.02% |
123,490
+1,000
| +0.8% | +$59.2K |
|
483
Organon & Co
OGN
$3.56B
| $8.19M | 0.02% |
+270,673
| New | +$8.91M |
|
484
MKS Inc
MKSI
$21.3B
| $8.16M | 0.02% |
45,883
+520
| +1% | +$94.5K |
|
485
Fox Class B
FOX
$21.3B
| $8.15M | 0.02% |
231,590
-82,915
| -26% | -$3M |
|
486
Lamb Weston
LW
$7.3B
| $8.15M | 0.02% |
101,008
-258,033
| -72% | -$20.7M |
|
487
Commerce Bancshares
CBSH
$8.49B
| $8.14M | 0.02% |
139,330
-728
| -0.5% | -$43.9K |
|
488
SBA Communications
SBAC
$18.3B
| $8.13M | 0.02% |
25,501
-2,090
| -8% | -$627K |
|
489
Hubbell
HUBB
$26.3B
| $8.12M | 0.02% |
43,477
-3,790
| -8% | -$716K |
|
|
Y
490
DELISTED
Alleghany Corp
Y
| $8.08M | 0.02% |
12,117
+215
| +2% | +$148K |
|
491
SLM Corp
SLM
$4.78B
| $8.01M | 0.02% |
382,288
+43,625
| +13% | +$859K |
|
492
Sunrun
RUN
$2.38B
| $7.93M | 0.02% |
142,100
+12,300
| +9% | +$594K |
|
|
MRTX
493
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $7.89M | 0.02% |
48,872
+22,135
| +83% | +$3.55M |
|
494
Broadridge
BR
$17.7B
| $7.84M | 0.02% |
48,540
+1,495
| +3% | +$239K |
|
495
Labcorp
LH
$24.7B
| $7.82M | 0.02% |
32,996
+640
| +2% | +$146K |
|
|
CNTA
496
DELISTED
Centessa Pharmaceuticals
CNTA
| $7.77M | 0.02% |
+350,000
| New | +$8.23M |
|
497
Capri Holdings
CPRI
$1.82B
| $7.77M | 0.02% |
135,865
-15,030
| -10% | -$818K |
|
498
Trupanion
TRUP
$1.08B
| $7.73M | 0.02% |
67,159
-2,317
| -3% | -$202K |
|
499
Leidos
LDOS
$14.5B
| $7.73M | 0.02% |
76,430
-8,025
| -10% | -$824K |
|
500
Twist Bioscience
TWST
$5.39B
| $7.72M | 0.02% |
57,979
+7,069
| +14% | +$822K |
|
Similar funds
SCP
Ensign Peak Advisors's Q2 2021 Portfolio in Review
As of Q2 2021, Ensign Peak Advisors held 1,890 positions worth $49.6B, up 6.6% from $46.5B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Ensign Peak Advisors's Q2 2021 filing shows 65 new, 583 increased, 472 reduced and 69 closed positions. Its largest new stake was Root: 151,917 shares worth $29.6M. The largest sale was Apple, an estimated $89.4M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
- Ensign Peak Advisors's largest Q2 2021 buy was Root: 151,917 shares worth $29.6M.
- Ensign Peak Advisors added most to iShares Core S&P 500 ETF in Q2 2021, an estimated $108M increase.
- Ensign Peak Advisors's biggest Q2 2021 reduction was Apple, cutting an estimated $89.4M.
- Ensign Peak Advisors fully exited W.R. Grace & Co. in Q2 2021, selling an estimated $20.5M.
- Ensign Peak Advisors's ten largest holdings make up 23% of its $49.6B portfolio in Q2 2021.
- Ensign Peak Advisors opened 65 new positions and closed 69 in Q2 2021.
- Ensign Peak Advisors's portfolio value rose 6.6% quarter-over-quarter to $49.6B.
Based on Ensign Peak Advisors's 13F filing for Q2 2021, filed 13 Aug 2021.